Author

Margaret H. Collins 1

1 University of Cincinnati, College of Medicine, Cincinnati, United States of America

A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF A NOVEL RECOMBINANT, HUMANISED, ANTI-INTERLEUKIN-13 MONOCLONAL ANTIBODY (RPC4046) IN PATIENTS WITH ACTIVE EOSINOPHILIC OESOPHAGITIS: RESULTS OF THE HEROES STUDY

Ikuo Hirano, Margaret H. Collins, Yudith Assouline-Dayan, Larry Evans, Sandeep Gupta, Alain Schoepfer, Michael Grimm, Heather Smith, Cindy-ann Tompkins, Amy Woo, Robert Peach, Paul A. Frohna, Sheila Gujrathi, Richard Aranda, Evan S Dellon

DEVELOPMENT OF A SYMPTOM-BASED ACTIVITY INDEX FOR EOSINOPHILIC ESOPHAGITIS

Alain Schoepfer, Alex Straumann, Radoslav Panczak, Yvonne Romero, Jeffrey Alexander, Ikuo Hirano, Nirmala Gonsalves, Glenn Furuta, Evan S Dellon, John Leung, Margaret H. Collins, Peter Netzer, Sandeep Gupta, Mirna Chehade, Fouad J. Moawad, Seema Aceves, John Wo, Ekaterina Safroneeva

DEVELOPMENT OF AN ENDOSCOPY- AND HISTOLOGY-BASED ACTIVITY INDEX FOR EOSINOPHILIC ESOPHAGITIS

Alain Schoepfer, Alex Straumann, Radoslav Panczak, Yvonne Romero, Jeffrey Alexander, Ikuo Hirano, Nirmala Gonsalves, Glenn Furuta, Evan S Dellon, John Leung, Margaret H. Collins, Peter Netzer, Sandeep Gupta, Mirna Chehade, Fouad J. Moawad, Seema Aceves, John Wo, Ekaterina Safroneeva

DUPILUMAB EFFICACY AND SAFETY IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM PART A OF A RANDOMIZED, PLACEBO-CONTROLLED THREE-PART, PHASE 3 STUDY

Evan S Dellon, Marc E. Rothenberg, Margaret H. Collins, Ikuo Hirano, Mirna Chehade, Arjan Bredenoord, Alfredo J. Lucendo, Jonathan Spergel, Qiong Zhao, Jennifer D. Hamilton, Bethany Beazley, Isabelle Guillemin, Siddhesh Kamat, Leda Mannent, Marcella Ruddy, Elizabeth Laws, Bolanle Akinlade, Nikhil Amin, Allen Radin, Brad

DUPILUMAB EFFICACY AND SAFETY IN ADULT PATIENTS WITH ACTIVE EOSINOPHILIC OESOPHAGITIS: A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 2 TRIAL

Ikuo Hirano, Evan S Dellon, Jennifer D. Hamilton, Margaret H. Collins, Kathryn Peterson, Mirna Chehade, Alain Schoepfer, Ekaterina Safroneeva, Marc E. Rothenberg, Gary W. Falk, Yehudith Assouline Dayan, Zhizhi Qing, Brian N. Swanson, Gianluca Pirozzi, Leda Mannent, Neil MH Graham, Bolanle Akinlade, Allen Radin

DUPILUMAB NORMALIZES EXPRESSION OF GENES ASSOCIATED WITH TYPE 2 INFLAMMATION IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS

Jennifer D. Hamilton, Margaret H. Collins, Wei Keat Lim, Sara Hamon, Matthew F. Wipperman, Allen Radin, Mirna Chehade, Ikuo Hirano, Evan S Dellon, Sivan Harel, William Brian, Leda Mannent, Marc E. Rothenberg

EFFICACY OF RPC4046, AN ANTI-INTERLEUKIN-13 MONOCLONAL ANTIBODY, IN PATIENTS WITH ACTIVE EOSINOPHILIC ESOPHAGITIS: ANALYSIS OF THE STEROID-REFRACTORY SUBGROUP FROM THE HEROES STUDY

Evan S Dellon, Margaret H. Collins, Yehudith Assouline Dayan, Larry Evans, Sandeep Gupta, Alain Schoepfer, Alex Straumann, Ekaterina Safroneeva, Amy Woo, Gregory J. Opiteck, Allan Olson, Richard Aranda, Marc E. Rothenberg, Ikuo Hirano

LONG-TERM EFFICACY AND SAFETY OF RPC4046, AN ANTI-INTERLEUKIN-13 MONOCLONAL ANTIBODY, IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE OPEN-LABEL EXTENSION OF THE HEROES STUDY

Evan S Dellon, Margaret H. Collins, Yehudith Assouline Dayan, Larry Evans, Sandeep Gupta, Alain Schoepfer, Alex Straumann, Ekaterina Safroneeva, Amy Woo, Allan Olson, Gregory J. Opiteck, Richard Aranda, Ikuo Hirano

MARKERS OF ESOPHAGEAL EPITHELIAL-MESENCHYMAL TRANSITION ARE SIGNIFICANTLY REDUCED IN ACTIVE EOSINOPHILIC ESOPHAGITIS FOLLOWING 16 WEEKS OF TREATMENT WITH RPC4046, AN ANTI-INTERLEUKIN-13 MONOCLONAL ANTIBODY

Peter Gann, Ryan Deaton, Nathan McMahon, Margaret H. Collins, Evan S Dellon, Ikuo Hirano, Michael Grimm, Amy Woo, Mahinda Karunaratne, Allan Olson, Richard Aranda, Gregory J. Opiteck

THE GENE EXPRESSION SIGNATURE MODULATED BY DUPILUMAB IS HIGHLY CORRELATED WITH EOSINOPHILIC ESOPHAGITIS HISTOLOGICAL SEVERITY

Margaret H. Collins

Item 1 - 10 / 11
1
2